Upper limit of serum PSA was used to be accepted as 4.0 ng/mL, however recent studies showed that in 20% of patients with prostate cancer PSA values are below 4.0 ng/mL and therefore currently the upper limit value is considered as 2.5 ng/mL [8]. Here, KLK3 is linked to prostate cancer.